688712 logo

Insight Lifetech Co., Ltd. Stock Price

SHSE:688712 Community·CN¥17.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688712 Share Price Performance

CN¥40.75
-8.89 (-17.91%)
CN¥40.75
-8.89 (-17.91%)
Price CN¥40.75

688712 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

1 Risk
1 Reward

Insight Lifetech Co., Ltd. Key Details

CN¥542.1m

Revenue

CN¥0

Cost of Revenue

CN¥542.1m

Gross Profit

CN¥461.5m

Other Expenses

CN¥80.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 25, 2026
0.19
100.00%
14.87%
7.0%
View Full Analysis

About 688712

Founded
2015
Employees
632
CEO
Liang Song
WebsiteView website
www.insight-med.com

Insight Lifetech Co., Ltd. develops and manufactures medical technology solutions focused on precision intravascular physiology and imaging for the diagnosis and treatment of cardiovascular diseases. The company provides products in precision intravascular physiology and imaging, including FFR (Fractional Flow Reserve) and IVUS (Intravascular Ultrasound) systems. Its product portfolio addresses the diagnosis and treatment of conditions such as coronary heart disease and coronary artery disease, with offerings that include TrueVision and VivoHeart IVUS systems. The company also provides clinical support and academic promotion related to its products, and engages in research and development, manufacturing, and commercialization of medical technologies. The company was founded in 2015 and is based in Shenzhen, China.

Recent 688712 News & Updates

Recent updates

No updates